ImmunityBio, Inc. (IBRX)
3.02
+0.20
(+7.09%)
USD |
NASDAQ |
Jan 14, 16:00
3.05
+0.03
(+0.99%)
After-Hours: 05:01
ImmunityBio Market Cap: 2.975B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.896B |
| Cytokinetics, Inc. | 7.898B |
| Altimmune, Inc. | 436.15M |
| Seres Therapeutics, Inc. | 140.77M |
| Relay Therapeutics, Inc. | 1.399B |
Market Cap Related Metrics
| PS Ratio | 31.30 |
| Price | 3.02 |
| Earnings Yield | -13.92% |